Experts and industry watchers fully expect the FDA to approve Biogen’s controversial Alzheimer’s disease drug aducanumabâbut not because it’s a game changer. In the words of one analyst, aducanumab won’t get the agency’s nod because its data are …
See Original Article
With Election Day behind us, many investors may be wondering whether now is a good time to buy stocks. Sure, political tension drags on and uncertainty remains. But market indexes have surged higher recently, suggesting the Street believes the worst of …
See Original Article
The Securities and Exchange Board of India (Sebi) has restored the pre-covid cut-off timings of mutual funds, effective 9 November. The regulator has sent a letter to industry body AMFI in this regard, a copy of which was seen by Mint. In April, Sebi had …
See Original Article
BOSTON (WHDH) – Commuters who fail to wear a face covering on any Massachusetts Bay Transportation Authority vehicle can face up to a $300 fine under Gov. Charlie Baker’s revised executive order. RELATED: Massachusetts’ new stay-at-home advisory, …
See Original Article
The unemployment rate fell to 6.9 from 7.9 percent, according to the Bureau of Labor Statistics, which releases the monthly employment report from data gathered during the first half of the preceding month. Eleven million people remain …
See Original Article